Specialty Pharmacy

Top developments from the last week in cancer treatment.

Researchers evaluate how DNA viruses work and how they can be stopped.

Opinions in the health care community vary on medical marijuana.

Findings could boost the efficacy of immunotherapy drugs.

Treatments skipped due to cost are at their lowest percentage since 1999.

Clinical outcomes expected to continue improving as new treatments arrive.

Top stories of the week on Specialty Pharmacy Times.

Multiple sclerosis advocate discusses the difficulties patients face during treatment.

New approach may combine with existing medications to improve survival.

Use of diabetes therapy may increase the risk of bone fracture.

Humira approved for the treatment of moderate to severe hidradenitis suppurativa.

Ixazomib is the first investigational oral proteasome inhibitor for relapsed and/or refractory multiple myeloma.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses the projected ramifications from the launch of biosimilars in the United States.

New method may improve treatment for a number of diseases.

Investigational drugs developed across specific types of lung, bladder, and skin cancers.

The role of vitamin D in diseases such as psoriatic arthritis, systemic lupus erythematosus, and rheumatoid arthritis.

Prophylactic treatment administered as a weekly subcutaneous injection for severe hemophilia A with and without inhibitors to factor VIII.

Pharmacist jailed for providing prescription drugs to individuals who did not see a physician or have valid prescriptions.

Alectinib is an oral anaplastic lymphoma kinase inhibitor for locally advanced or metastatic non-small cell lung cancer.

An FDA warning about compounded drugs stored in Becton-Dickinson (BD) syringes now applies to 4 more syringe sizes as well as oral syringes.

Daratumumab monotherapy slows disease progression a year after treatment.

The rare disease only afflicts 20 people worldwide.

Cell-to-cell transmission of HIV causes greater CD4 T cell death.

Researchers still seek to determine if vitamin D can make any difference in the course of MS after onset.

Researchers examine how a cell distinguishes between damaged DNA and foreign viral DNA.

Decrease found in chemotherapy use among patients with high-risk cancer and those who received genetic testing.

Researchers seek drug targets superior to nonsteroidal anti-inflammatory drugs.

Desire for future fertility has a negative impact on adherence to tamoxifen regimen.